Peter Alagona

1.4k total citations · 1 hit paper
17 papers, 991 citations indexed

About

Peter Alagona is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Peter Alagona has authored 17 papers receiving a total of 991 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 8 papers in Surgery and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Peter Alagona's work include Lipoproteins and Cardiovascular Health (6 papers), Cardiac pacing and defibrillation studies (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Peter Alagona is often cited by papers focused on Lipoproteins and Cardiovascular Health (6 papers), Cardiac pacing and defibrillation studies (5 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers). Peter Alagona collaborates with scholars based in United States. Peter Alagona's co-authors include Lawrence Laslett, Sean R. Wilson, Bernard A. Clark, Joseph P. Drozda, John R. Guyton, John B. Rodgers, Richard Sachson, Anne C. Goldberg, David M. Capuzzi and Paul Samuel and has published in prestigious journals such as Journal of the American College of Cardiology, CHEST Journal and The American Journal of Cardiology.

In The Last Decade

Peter Alagona

15 papers receiving 960 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues

2012 559 citations Lawrence Laslett, Peter Alagona et al. Journal of the American College of Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Peter Alagona United States	9	420	327	195	130	80	17	991
Margus Viigimaa Estonia	18	410 1.0×	282 0.9×	311 1.6×	159 1.2×	68 0.8×	83	1.2k
Judith A. Finegold United Kingdom	12	527 1.3×	428 1.3×	114 0.6×	141 1.1×	62 0.8×	21	1.3k
Federico Vancheri Italy	13	463 1.1×	238 0.7×	130 0.7×	134 1.0×	48 0.6×	45	1.1k
Michael F. Oliver United Kingdom	20	656 1.6×	544 1.7×	258 1.3×	120 0.9×	86 1.1×	37	1.3k
Kee‐Sik Kim South Korea	16	503 1.2×	255 0.8×	135 0.7×	113 0.9×	51 0.6×	58	989
Yuichiro Goto Japan	16	312 0.7×	431 1.3×	299 1.5×	156 1.2×	124 1.6×	105	1.1k
Charles German United States	15	324 0.8×	202 0.6×	161 0.8×	100 0.8×	49 0.6×	51	869
Radu Huculeci United Kingdom	10	435 1.0×	144 0.4×	87 0.4×	142 1.1×	44 0.6×	22	986
Moo‐Yong Rhee South Korea	20	683 1.6×	275 0.8×	216 1.1×	197 1.5×	78 1.0×	92	1.4k

Countries citing papers authored by Peter Alagona

Since Specialization

Citations

This map shows the geographic impact of Peter Alagona's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Alagona with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Alagona more than expected).

Fields of papers citing papers by Peter Alagona

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Alagona. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Alagona. The network helps show where Peter Alagona may publish in the future.

Co-authorship network of co-authors of Peter Alagona

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Alagona. A scholar is included among the top collaborators of Peter Alagona based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Alagona. Peter Alagona is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Lin, Jonathan H., et al.. (2018). Achieving Guideline-Driven High-Intensity Statin Dose in Cardiac Rehabilitation Patients With Coronary Artery Disease. Journal of Cardiopulmonary Rehabilitation and Prevention. 38(5). E1–E4.

Sun, Susie X., et al.. (2015). Positive predictive value of an elevated cardiac troponin for type I myocardial infarction in ED patients based on the chief complaint. The American Journal of Emergency Medicine. 33(4). 516–520. 4 indexed citations

Alagona, Peter & Tariq Ali Ahmad. (2015). Cardiovascular Disease Risk Assessment and Prevention. Medical Clinics of North America. 99(4). 711–731. 34 indexed citations

Laslett, Lawrence, et al.. (2012). The Worldwide Environment of Cardiovascular Disease: Prevalence, Diagnosis, Therapy, and Policy Issues. Journal of the American College of Cardiology. 60(25). S1–S49. 559 indexed citations breakdown →

Li, Xian, Michele L. Shaffer, Sol Rodríguez-Colón, et al.. (2011). The circadian pattern of cardiac autonomic modulation in a middle-aged population. Clinical Autonomic Research. 21(3). 143–150. 47 indexed citations

Cheriyath, Pramil, Fan He, Xian Li, et al.. (2011). Relation of Atrial and/or Ventricular Premature Complexes on a Two-Minute Rhythm Strip to the Risk of Sudden Cardiac Death (the Atherosclerosis Risk in Communities [ARIC] Study). The American Journal of Cardiology. 107(2). 151–155. 56 indexed citations

Alagona, Peter. (2010). Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia. Vascular Health and Risk Management. 6. 351–351. 26 indexed citations

Alagona, Peter. (2010). Pitavastatin: evidence for its place in treatment of hypercholesterolemia. PubMed. 5. 91–91. 19 indexed citations

Alagona, Peter. (2009). Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.. PubMed. 15(3 Suppl). S65–73. 34 indexed citations

10.

Alexandrov, Andrei V. & Peter Alagona. (2008). Stroke and atherothrombosis: An Update on the Role of Antiplatelet Therapy. International Journal of Stroke. 3(3). 175–181. 8 indexed citations

11.

Goldberg, Anne C., Peter Alagona, David M. Capuzzi, et al.. (2000). Multiple-dose efficacy and safety of an extended-release form of niacin in the management of hyperlipidemia. The American Journal of Cardiology. 85(9). 1100–1105. 179 indexed citations

12.

Naccarelli, Gerald V., et al.. (1997). Can Electrophysiologists Survive the New Era of Health Care Reform?. Pacing and Clinical Electrophysiology. 20(8). 2008–2011.

13.

Alagona, Peter. (1997). Advances in pacing for the patient with sick sinus syndrome. Current Opinion in Cardiology. 12(1). 3–11. 8 indexed citations

14.

Alagona, Peter, et al.. (1994). Regional distribution of 2-deoxy-2[18F]-fluoro-D-glucose for metabolic imaging using positron emission tomography. International journal of cardiac imaging. 10(2). 137–143. 4 indexed citations

15.

Benditt, David G., Peter Alagona, Magdi Ghali, et al.. (1993). Late follow-up of dual-chamber rate-adaptive pacing. The American Journal of Cardiology. 71(8). 714–719. 5 indexed citations

16.

Alagona, Peter. (1991). TEMPORARY CARDIAC PACING. CHEST Journal. 100(5). 16–16. 2 indexed citations

17.

Spencer, William H., Toby Markowitz, & Peter Alagona. (1990). Rate Augmentation and Atrial Arrhythmias in DDDR Pacing. Pacing and Clinical Electrophysiology. 13(12). 1847–1851. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact